At the same time, we found through The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD) database demonstrated that the disease free survival of the Low CSRP1 group was worse than that of the High CSRP1 group (Fig. 4C). Here, CSRP1 is linked to prostate adenocarcinoma.